↓ Skip to main content

Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART)

Overview of attention for article published in British Medical Journal, July 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

news
14 news outlets
blogs
2 blogs
twitter
107 X users
facebook
4 Facebook pages
guideline
3 clinical guideline sources

Readers on

mendeley
516 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 107 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 516 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 516 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Master 35 7%
Student > Bachelor 33 6%
Researcher 28 5%
Other 24 5%
Student > Ph. D. Student 22 4%
Other 67 13%
Unknown 307 59%
Readers by discipline
Readers by discipline Count As %
Nursing and Health Professions 63 12%
Medicine and Dentistry 61 12%
Psychology 13 3%
Computer Science 9 2%
Pharmacology, Toxicology and Pharmaceutical Science 8 2%
Other 48 9%
Unknown 314 61%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 179. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 December 2025.
All research outputs
#283,564
of 34,563,371 outputs
Outputs from British Medical Journal
#3,100
of 75,874 outputs
Outputs of similar age
#6,230
of 476,097 outputs
Outputs of similar age from British Medical Journal
#83
of 683 outputs
Altmetric has tracked 34,563,371 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 75,874 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.4. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 476,097 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 683 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.